Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy.

Vaccines (Basel) · 2023 · PMC10537223 · PMID 37766140

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In anti-CD20-treated pwMS, there was only a declining trend in antibody titers until six months after primary vaccination that did not reach statistical significance, but booster vaccination also led to significantly higher titers compared to primary vaccination.

also in 111,027 other papers

a decreasing trendno p-value reported

T-cell response presented a decreasing trend after primary and booster vaccination in both groups; however, this was not statistically significant ( Figure 5 B,C).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.